Clinical Pathways

Clinical pathways in health care are standardized medical guidelines that define the specific steps in the treatment of various diseases or medical conditions. They are created by medical professionals and health organizations in order to improve the quality of health services, optimize resources and ensure efficiency and consistency in treatment.
Clinical pathways include recommendations for diagnosis, treatment, monitoring and completion of the treatment process, aiming to ensure the best possible patient outcomes.
Due to the specifics of health care and the presence of medical specialists in the health facility, each one with a contract with the NHIF serves patients on a certain number of clinical paths.

Clinical pathways related to the treatment of oncological diseases in Bulgaria

This list is updated regularly and provides information on different clinical pathways through which cancer treatment can be carried out in Bulgaria. These clinical pathways will be different depending on the treatment facility you choose, so always look for up-to-date clinical pathway information that is available prominently within the facility itself, as well as on the official website or other communication channels.
In addition to admission through clinical pathways, patients can also be diagnosed by undergoing established outpatient procedures.

Clinical pathways (for Bulgaria)

• CP 43 Bronchoscopic procedures of small volume and complexity in pulmonology
• CP No. 44 Highly specialized interventional procedures in pulmonology
• CP No. 141 Transurethral surgical treatment for oncological diseases of the bladder
• CP No. 160 Non-radical removal of the uterus
• CP No. 161 Radical removal of female genital organs
• CP No. 162 Operative interventions through abdominal access for the removal of pathological changes of the female genital organs
• CP No. 163 Operative interventions through lower access for the removal of pathological changes or invasive examination of the female genital organs
• CP #164 Corrections of pelvic (perineal) static and/or urinary incontinence in women
• CP #167 Systemic radical excision of lymph nodes (pelvic and/or para-aortic and/or inguinal) as a stand-alone intervention or combined with radical removal of female genital organs. Pelvic exenteration
• CP №171 Operative procedures of esophagus, stomach and duodenum of large and very large volume and complexity, in persons over 18 years old
• CP No. 172 Operative procedures of the esophagus, stomach and duodenum of large and very large volume and complexity in persons under 18 years old
• CP №173 Operative procedures of esophagus, stomach and duodenum of medium volume and complexity, in persons over 18 years old
• CP №175 Operative procedures of small and large intestines, incl. In diseases of the mesentery and retroperitoneum of large and very large volume and complexity, in persons over 18 years old
• CP №177 Operative procedures of small and large intestines of medium volume and complexity, in persons over 18 years old
• CP #187 Operative procedures on the liver
• CP №193 Operative treatment of breast cancer: stages Tis 1-4 N 0-2 M0-1
• CP #194 Operative interventions on the breast with local excision and biopsy
• CP №199.1 Treatment of skin and mucous membrane tumors - malignant neoplasms
• CP №199.2 Treatment of tumors of the skin and mucous membranes - benign neoplasms
• CP №213 Operative treatment of tumors of the lung, mediastinum, pleura and chest wall
• CP #240 Long-term systemic parenteral drug treatment of malignant solid tumors and related complications
• CP #241 Diagnostic procedures for staging and evaluation of therapeutic response in patients with malignant solid tumors and hematological diseases
• Diagnosis and treatment of leukemias
• Diagnosis and treatment of lymphomas
• Low Activity Brachytherapy
• High-tech radiotherapy of oncological and non-oncological diseases with applied up to 20 fractions and duration of treatment from 3 to 30 days
• High-tech radiotherapy of oncological and diseases with applied 20 and more fractions and duration of treatment 30 and more days
• Intensity-modulated radiotherapy of oncological and non-oncological diseases with up to 20 fractions applied and duration of treatment from 3 to 30 days
• Intensity-modulated radiotherapy of oncological and non-oncological diseases with applied 20 and more fractions and duration of treatment 30 and more days
• Radiosurgery of oncological and non-oncological diseases

Outpatient Procedures

• Ambulatory procedure #4 Provision of permanent access for dialysis treatment and chemotherapy
• Outpatient procedure #05 Determination of treatment plan for patients with malignant diseases.
• Outpatient procedure #06 Systemic drug treatment for malignant solid tumors.
• Ambulatory procedure #07 Dispensary monitoring for malignant diseases
• Outpatient procedure #08 Monitoring of therapeutic response in patients on home treatment with targeted oral antitumor therapy and oral chemotherapy
• Ambulatory procedure No. 38 Determination of a treatment plan and monitoring of the therapeutic response in patients receiving expensive medicinal products in accordance with Article 78, Item 2, Health Insurance
• Outpatient procedure #44 Diagnosis of malignant breast diseases